VTAK Relative Valuation
VTAK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VTAK is overvalued; if below, it's undervalued.
Historical Valuation
Catheter Precision Inc (VTAK) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -0.29. The fair price of Catheter Precision Inc (VTAK) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：2.34
Fair
-0.20
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Catheter Precision Inc. (VTAK) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-0.38
EV/EBIT
Catheter Precision Inc. (VTAK) has a current EV/EBIT of -0.38. The 5-year average EV/EBIT is -0.18. The thresholds are as follows: Strongly Undervalued below -0.63, Undervalued between -0.63 and -0.40, Fairly Valued between 0.05 and -0.40, Overvalued between 0.05 and 0.28, and Strongly Overvalued above 0.28. The current Forward EV/EBIT of -0.38 falls within the Historic Trend Line -Fairly Valued range.
1.04
PS
Catheter Precision Inc. (VTAK) has a current PS of 1.04. The 5-year average PS is 0.57. The thresholds are as follows: Strongly Undervalued below -0.44, Undervalued between -0.44 and 0.07, Fairly Valued between 1.07 and 0.07, Overvalued between 1.07 and 1.57, and Strongly Overvalued above 1.57. The current Forward PS of 1.04 falls within the Historic Trend Line -Fairly Valued range.
-0.53
P/OCF
Catheter Precision Inc. (VTAK) has a current P/OCF of -0.53. The 5-year average P/OCF is -0.33. The thresholds are as follows: Strongly Undervalued below -0.89, Undervalued between -0.89 and -0.61, Fairly Valued between -0.04 and -0.61, Overvalued between -0.04 and 0.24, and Strongly Overvalued above 0.24. The current Forward P/OCF of -0.53 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Catheter Precision Inc. (VTAK) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Catheter Precision Inc (VTAK) has a current Price-to-Book (P/B) ratio of 0.58. Compared to its 3-year average P/B ratio of 0.24 , the current P/B ratio is approximately 140.14% higher. Relative to its 5-year average P/B ratio of 0.24, the current P/B ratio is about 140.14% higher. Catheter Precision Inc (VTAK) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -433.58%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -433.58% , the current FCF yield is about -100.00% lower.
0.59
P/B
Median3y
0.24
Median5y
0.24
-243.41
FCF Yield
Median3y
-433.58
Median5y
-433.58
Competitors Valuation Multiple
The average P/S ratio for VTAK's competitors is 0.00, providing a benchmark for relative valuation. Catheter Precision Inc Corp (VTAK) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 135.42%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of VTAK decreased by 71.76% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 96.00K to 226.00K.
The secondary factor is the Margin Expansion, contributed -75.83%to the performance.
Overall, the performance of VTAK in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Catheter Precision Inc (VTAK) currently overvalued or undervalued?
What is Catheter Precision Inc (VTAK) fair value?
How does VTAK's valuation metrics compare to the industry average?
What is the current P/B ratio for Catheter Precision Inc (VTAK) as of Dec 05 2025?
What is the current FCF Yield for Catheter Precision Inc (VTAK) as of Dec 05 2025?
What is the current Forward P/E ratio for Catheter Precision Inc (VTAK) as of Dec 05 2025?